应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01875 东曜药业-B
提前休市 12-24 09:00:01
1.600
+0.000
0.00%
最高
1.600
最低
1.600
成交量
0.00
今开
1.600
昨收
1.600
日振幅
0.00%
总市值
12.36亿
流通市值
12.36亿
总股本
7.73亿
成交额
0.00
换手率
0.00%
流通股本
7.73亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
东曜药业-B盘中异动 快速上涨7.43%
市场透视 · 12-16
东曜药业-B盘中异动 快速上涨7.43%
东曜药业-B盘中异动 股价大跌6.91%
市场透视 · 12-12
东曜药业-B盘中异动 股价大跌6.91%
东曜药业(01875.HK)荣获“年度卓越高端制造企业”,有哪些价值增量值得关注?
格隆汇 · 12-11
东曜药业(01875.HK)荣获“年度卓越高端制造企业”,有哪些价值增量值得关注?
东曜药业-B盘中异动 早盘股价大涨6.15%报1.900港元
市场透视 · 12-09
东曜药业-B盘中异动 早盘股价大涨6.15%报1.900港元
东曜药业-B盘中异动 股价大涨6.70%报1.910港元
市场透视 · 12-05
东曜药业-B盘中异动 股价大涨6.70%报1.910港元
东曜药业-B股价拉升12.12% 市值涨1.73亿港元
市场透视 · 11-29
东曜药业-B股价拉升12.12% 市值涨1.73亿港元
东曜药业-B(01875)股价显著上升12.121%,现价港币$1.85
阿斯达克财经 · 11-29
东曜药业-B(01875)股价显著上升12.121%,现价港币$1.85
东曜药业-B股价重挫12.23% 市值跌1.56亿港元
市场透视 · 11-28
东曜药业-B股价重挫12.23% 市值跌1.56亿港元
东曜药业-B盘中异动 急速下跌5.91%报1.750港元
市场透视 · 11-13
东曜药业-B盘中异动 急速下跌5.91%报1.750港元
东曜药业(01875.HK)首九个月纯利3,540万人民币 亏转盈
阿斯达克财经 · 11-13
东曜药业(01875.HK)首九个月纯利3,540万人民币 亏转盈
东曜药业-B(01875)前三季度营业收入同比增长49%至8.09亿元
智通财经 · 11-12
东曜药业-B(01875)前三季度营业收入同比增长49%至8.09亿元
异动解读 | 生物技术板块走强 东曜药业-B股价大涨5.88%
异动解读 · 11-12
异动解读 | 生物技术板块走强 东曜药业-B股价大涨5.88%
东曜药业-B(01875)股价显著上升10.588%,现价港币$1.88
阿斯达克财经 · 11-12
东曜药业-B(01875)股价显著上升10.588%,现价港币$1.88
东曜药业-B盘中异动 大幅拉升5.88%
市场透视 · 11-12
东曜药业-B盘中异动 大幅拉升5.88%
东曜药业-B盘中异动 早盘股价大涨8.28%
市场透视 · 11-11
东曜药业-B盘中异动 早盘股价大涨8.28%
东曜药业-B盘中异动 早盘快速上涨7.65%
市场透视 · 11-08
东曜药业-B盘中异动 早盘快速上涨7.65%
东曜药业-B盘中异动 下午盘大幅下跌5.56%报1.700港元
市场透视 · 11-05
东曜药业-B盘中异动 下午盘大幅下跌5.56%报1.700港元
东曜药业-B(01875)出现大手买入97万股,成交价$1.97,涉资191.09万
阿斯达克财经 · 10-18
东曜药业-B(01875)出现大手买入97万股,成交价$1.97,涉资191.09万
东曜药业-B上榜10月17日主力资金加仓幅度前10个股(附名单)
市场透视 · 10-17
东曜药业-B上榜10月17日主力资金加仓幅度前10个股(附名单)
东曜药业-B(01875)下跌5.05%,报1.88元/股
金融界 · 10-17
东曜药业-B(01875)下跌5.05%,报1.88元/股
公司概况
公司名称:
东曜药业-B
所属市场:
SEHK
上市日期:
--
主营业务:
东曜药业于2019年在香港联交所主板上市,2021年全面转型,致力于成为全球药物开发领域专业CDMO合作伙伴,提供生物药开发到生产一站式解决方案。 公司拥有从研发、工艺开发、临床试验、注册报批到商业化生产的全流程经验,建立了完整的ADC技术平台,具备核心偶联工艺和放大的技术优势,以及ADC关键质量属性的自主分析能力,保证产品高质量开发。
发行价格:
--
{"stockData":{"symbol":"01875","market":"HK","secType":"STK","nameCN":"东曜药业-B","latestPrice":1.6,"timestamp":1735002001001,"preClose":1.6,"halted":0,"volume":0,"delay":0,"floatShares":772787887,"shares":772787887,"eps":-0.055332657,"marketStatus":"提前休市","marketStatusCode":6,"change":0,"latestTime":"12-24 09:00:01","open":1.6,"high":1.6,"low":1.6,"amount":0,"amplitude":0,"askPrice":1.75,"askSize":48000,"bidPrice":1.6,"bidSize":1200,"shortable":0,"etf":0,"ttmEps":0.013138105184678948,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735263000000},"adr":0,"listingDate":1573142400000,"adjPreClose":1.6,"openAndCloseTimeList":[[1735003800000,1735012800000]],"volumeRatio":0,"lotSize":400,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01875/wiki","defaultTab":"wiki","newsList":[{"id":"2491681882","title":"东曜药业-B盘中异动 快速上涨7.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491681882","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491681882?lang=zh_cn&edition=full","pubTime":"2024-12-16 09:42","pubTimestamp":1734313377,"startTime":"0","endTime":"0","summary":"2024年12月16日早盘09时42分,东曜药业-B股票出现异动,股价快速上涨7.43%。东曜药业-B股票所在的生物技术行业中,整体涨幅为0.16%。其相关个股中,东曜药业-B、云康集团、晶泰控股-P涨幅较大,振幅较大的相关个股有创胜集团-B、加科思-B、永泰生物-B,振幅分别为18.03%、11.59%、9.09%。东曜药业-B公司简介:东曜药业股份有限公司是一家临床阶段生物制药公司,主要从事开发及商业化肿瘤药物及疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216094257984c5609&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216094257984c5609&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01875","BK1574","BK1161"],"gpt_icon":0},{"id":"2490687808","title":"东曜药业-B盘中异动 股价大跌6.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490687808","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490687808?lang=zh_cn&edition=full","pubTime":"2024-12-12 14:52","pubTimestamp":1733986369,"startTime":"0","endTime":"0","summary":"2024年12月12日下午盘14时52分,东曜药业-B股票出现异动,股价快速跳水6.91%。截至发稿,该股报1.750港元/股,成交量3.28万股,换手率0.00%,振幅6.91%。东曜药业-B股票所在的生物技术行业中,整体跌幅为0.08%。东曜药业-B公司简介:东曜药业股份有限公司是一家临床阶段生物制药公司,主要从事开发及商业化肿瘤药物及疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212145249a1e854ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212145249a1e854ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01875","BK1161"],"gpt_icon":0},{"id":"2490581008","title":"东曜药业(01875.HK)荣获“年度卓越高端制造企业”,有哪些价值增量值得关注?","url":"https://stock-news.laohu8.com/highlight/detail?id=2490581008","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490581008?lang=zh_cn&edition=full","pubTime":"2024-12-11 10:03","pubTimestamp":1733882597,"startTime":"0","endTime":"0","summary":"如今,东曜药业正站在一个新的起点上,未来有望实现快速成长,并在全球药物开发领域中扮演更加重要的角色。","market":"sg","thumbnail":"https://img7.gelonghui.com/column/5.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/5.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1461548","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1161","01875","BK1574"],"gpt_icon":0},{"id":"2490493760","title":"东曜药业-B盘中异动 早盘股价大涨6.15%报1.900港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490493760","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490493760?lang=zh_cn&edition=full","pubTime":"2024-12-09 09:53","pubTimestamp":1733709219,"startTime":"0","endTime":"0","summary":"2024年12月09日早盘09时53分,东曜药业-B股票出现波动,股价快速拉升6.15%。截至发稿,该股报1.900港元/股,成交量400股,换手率0.00%,振幅0.00%。资金方面,该股资金流入760港元,流出0港元。东曜药业-B股票所在的生物技术行业中,整体涨幅为1.03%。东曜药业-B公司简介:东曜药业股份有限公司是一家临床阶段生物制药公司,主要从事开发及商业化肿瘤药物及疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209095339ab6879c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209095339ab6879c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01875","BK1574"],"gpt_icon":0},{"id":"2489510103","title":"东曜药业-B盘中异动 股价大涨6.70%报1.910港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489510103","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489510103?lang=zh_cn&edition=full","pubTime":"2024-12-05 11:33","pubTimestamp":1733369581,"startTime":"0","endTime":"0","summary":"2024年12月05日临近午盘11时33分,东曜药业-B股票出现波动,股价快速上涨6.70%。截至发稿,该股报1.910港元/股,成交量400股,换手率0.00%,振幅0.00%。资金方面,该股资金流入764港元,流出0港元。东曜药业-B股票所在的生物技术行业中,整体跌幅为0.90%。东曜药业-B公司简介:东曜药业股份有限公司是一家临床阶段生物制药公司,主要从事开发及商业化肿瘤药物及疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205113301971bc3bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205113301971bc3bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01875","BK1574","BK1161"],"gpt_icon":0},{"id":"2487080633","title":"东曜药业-B股价拉升12.12% 市值涨1.73亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487080633","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487080633?lang=zh_cn&edition=full","pubTime":"2024-11-29 11:15","pubTimestamp":1732850119,"startTime":"0","endTime":"0","summary":"2024年11月29日早盘11时15分,东曜药业-B股票出现波动,股价大幅拉升12.12%。截至发稿,该股报1.850港元/股,成交量400股,换手率0.00%,振幅0.00%。东曜药业-B股票所在的生物技术行业中,整体涨幅为1.35%。其相关个股中,东曜药业-B、荃信生物-B、百济神州涨幅较大,振幅较大的相关个股有晶泰科技、来凯医药-B、博安生物,振幅分别为10.20%、7.80%、6.83%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129111519a25e01ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129111519a25e01ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01875","BK1161"],"gpt_icon":0},{"id":"2487308056","title":"东曜药业-B(01875)股价显著上升12.121%,现价港币$1.85","url":"https://stock-news.laohu8.com/highlight/detail?id=2487308056","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487308056?lang=zh_cn&edition=full","pubTime":"2024-11-29 11:15","pubTimestamp":1732850100,"startTime":"0","endTime":"0","summary":"[上升股]东曜药业-B(01875) 股价在上午11:15比前收市价显著上升12.121%,现股价为港币$1.85。至目前为止,今日最高价为$1.85,而最低价为$1.85。总成交量为400股,总成交金额为港币$740。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR241129510/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","01875","BK1574"],"gpt_icon":0},{"id":"2486638603","title":"东曜药业-B股价重挫12.23% 市值跌1.56亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486638603","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486638603?lang=zh_cn&edition=full","pubTime":"2024-11-28 14:56","pubTimestamp":1732776976,"startTime":"0","endTime":"0","summary":"2024年11月28日下午盘14时56分,东曜药业-B股票出现波动,股价快速跳水12.23%。截至发稿,该股报1.650港元/股,成交量8800股,换手率0.00%,振幅0.00%。资金方面,该股资金流入0港元,流出1.452万港元。东曜药业-B股票所在的生物技术行业中,整体跌幅为1.00%。其相关个股中,永泰生物-B、华康生物医学、亚盛医药-B涨幅较大,振幅较大的相关个股有帝王国际投资、永泰生物-B、宜明昂科-B,振幅分别为30.19%、23.12%、15.68%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128145616abe52598&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128145616abe52598&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01875","BK1574"],"gpt_icon":0},{"id":"2483604499","title":"东曜药业-B盘中异动 急速下跌5.91%报1.750港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483604499","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483604499?lang=zh_cn&edition=full","pubTime":"2024-11-13 14:06","pubTimestamp":1731477987,"startTime":"0","endTime":"0","summary":"2024年11月13日下午盘14时06分,东曜药业-B股票出现异动,股价快速跳水5.91%。截至发稿,该股报1.750港元/股,成交量8.52万股,换手率0.01%,振幅2.69%。资金方面,该股资金流入0港元,流出15.27万港元。东曜药业-B股票所在的生物技术行业中,整体跌幅为2.06%。其相关个股中,正大企业国际、腾盛博药-B、贝康医疗-B涨幅较大,振幅较大的相关个股有宜明昂科-B、正大企业国际、科济药业-B,振幅分别为23.63%、20.75%、14.29%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113140627971a6358&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113140627971a6358&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01875","BK1574"],"gpt_icon":0},{"id":"2483304620","title":"东曜药业(01875.HK)首九个月纯利3,540万人民币 亏转盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2483304620","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483304620?lang=zh_cn&edition=full","pubTime":"2024-11-13 02:50","pubTimestamp":1731437400,"startTime":"0","endTime":"0","summary":"东曜药业-B(01875.HK) 公布9月止九个月财务资料,营业收入8.09亿人民币(下同),按年增加49.3%。录得纯利3,540万元,相较上年同期亏损3,239万元,亏转盈。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2024/08/13中期业绩无派息2024/05/10第一季业绩无派息2024/03/15末期业绩无派息2023/11/10第三季业绩无派息AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220720120328644_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220720120328644_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1396109/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","BK1574","01875"],"gpt_icon":0},{"id":"2482085683","title":"东曜药业-B(01875)前三季度营业收入同比增长49%至8.09亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482085683","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482085683?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:37","pubTimestamp":1731422262,"startTime":"0","endTime":"0","summary":"智通财经APP讯,东曜药业-B(01875)发布公告,截至2024年9月30日止九个月期间,集团的营业收入同比增长49%至人民币8.09亿元,主要是由于自研产品销售及CDMO/CMO业务的稳步增长。净利润达3540.3万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1210120.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01875"],"gpt_icon":0},{"id":"1187702930","title":"异动解读 | 生物技术板块走强 东曜药业-B股价大涨5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=1187702930","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187702930?lang=zh_cn&edition=full","pubTime":"2024-11-12 12:22","pubTimestamp":1731385370,"startTime":"0","endTime":"0","summary":"生物技术板块整体表现强劲,东曜药业-B(01875)股价今日盘中时出现大涨5.88%的走势,引发市场关注。根据最新财务数据,东曜药业上一财年实现营收5.70亿港元,净利3457万港元。\n\n东曜药业-B作为一家临床阶段生物制药公司,主要从事抗肿瘤药物的研发、生产和销售。目前公司在抗癌药物方面拥有多个在研管线项目。分析人士认为,公司在抗癌药物研发方面或取得进展,加之整个行业前景向好,推动了公司股价的大涨。\n\n不过,由于缺乏直接相关新闻消息,东曜药业-B股价是否能持续上涨需持续观察。未来公司研发进展、财报数据等将继续影响公司股价走势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01875"],"gpt_icon":0},{"id":"2482717749","title":"东曜药业-B(01875)股价显著上升10.588%,现价港币$1.88","url":"https://stock-news.laohu8.com/highlight/detail?id=2482717749","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482717749?lang=zh_cn&edition=full","pubTime":"2024-11-12 11:59","pubTimestamp":1731383940,"startTime":"0","endTime":"0","summary":"[上升股]东曜药业-B(01875) 股价在上午11:59比前收市价显著上升10.588%,现股价为港币$1.88。至目前为止,今日最高价为$1.88,而最低价为$1.8。总成交量为13.24万股,总成交金额为港币$24.392万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2411121441/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","01875","BK1574"],"gpt_icon":0},{"id":"2482195947","title":"东曜药业-B盘中异动 大幅拉升5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482195947","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482195947?lang=zh_cn&edition=full","pubTime":"2024-11-12 11:11","pubTimestamp":1731381068,"startTime":"0","endTime":"0","summary":"2024年11月12日早盘11时11分,东曜药业-B股票出现波动,股价大幅拉升5.88%。截至发稿,该股报1.800港元/股,成交量3.52万股,换手率0.00%,振幅0.00%。东曜药业-B股票所在的生物技术行业中,整体涨幅为0.46%。东曜药业-B公司简介:东曜药业股份有限公司是一家临床阶段生物制药公司,主要从事开发及商业化肿瘤药物及疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112111108971a5e1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112111108971a5e1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","01875"],"gpt_icon":0},{"id":"2482451372","title":"东曜药业-B盘中异动 早盘股价大涨8.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482451372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482451372?lang=zh_cn&edition=full","pubTime":"2024-11-11 10:18","pubTimestamp":1731291498,"startTime":"0","endTime":"0","summary":"2024年11月11日早盘10时18分,东曜药业-B股票出现异动,股价急速上涨8.28%。截至发稿,该股报1.830港元/股,成交量800股,换手率0.00%,振幅0.00%。东曜药业-B股票所在的生物技术行业中,整体跌幅为0.83%。东曜药业-B公司简介:东曜药业股份有限公司是一家临床阶段生物制药公司,主要从事开发及商业化肿瘤药物及疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111101818abb45d0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111101818abb45d0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01875","BK1161","BK1587","02171","BK1574","BK1585"],"gpt_icon":0},{"id":"2481164550","title":"东曜药业-B盘中异动 早盘快速上涨7.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481164550","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481164550?lang=zh_cn&edition=full","pubTime":"2024-11-08 10:19","pubTimestamp":1731032352,"startTime":"0","endTime":"0","summary":"2024年11月08日早盘10时19分,东曜药业-B股票出现波动,股价大幅上涨7.65%。东曜药业-B股票所在的生物技术行业中,整体涨幅为0.76%。其相关个股中,科济药业-B、康宁杰瑞制药-B、帝王国际投资涨幅较大,振幅较大的相关个股有科济药业-B、康宁杰瑞制药-B、帝王国际投资,振幅分别为29.66%、19.64%、15.79%。东曜药业-B公司简介:东曜药业股份有限公司是一家临床阶段生物制药公司,主要从事开发及商业化肿瘤药物及疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110810191298e415b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110810191298e415b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02171","BK1585","BK1587","01875","BK1574","09966","BK1161"],"gpt_icon":0},{"id":"2481761542","title":"东曜药业-B盘中异动 下午盘大幅下跌5.56%报1.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481761542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481761542?lang=zh_cn&edition=full","pubTime":"2024-11-05 15:18","pubTimestamp":1730791085,"startTime":"0","endTime":"0","summary":"2024年11月05日下午盘15时18分,东曜药业-B股票出现异动,股价大幅跳水5.56%。截至发稿,该股报1.700港元/股,成交量5.28万股,换手率0.01%,振幅1.67%。资金方面,该股资金流入1.2384万港元,流出7.6512万港元。东曜药业-B股票所在的生物技术行业中,整体涨幅为0.84%。其相关个股中,迈博药业-B、泰格医药、药明康德涨幅较大,振幅较大的相关个股有晶泰科技、来凯医药-B、绿竹生物-B,振幅分别为14.42%、13.34%、10.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105151805971a45f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105151805971a45f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","01875"],"gpt_icon":0},{"id":"2476479327","title":"东曜药业-B(01875)出现大手买入97万股,成交价$1.97,涉资191.09万","url":"https://stock-news.laohu8.com/highlight/detail?id=2476479327","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476479327?lang=zh_cn&edition=full","pubTime":"2024-10-18 15:34","pubTimestamp":1729236840,"startTime":"0","endTime":"0","summary":"[大手成交]东曜药业-B(01875)在下午03:34出现大手买入,成交量为97万,成交价为港币$1.97,涉资191.09万。至目前为止,股价跌1.01%,今日最高价为$1.97,而最低价为$1.92,总成交量为200万股,总成交金额港币$392.85万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV24101811365/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","01875","BK1574"],"gpt_icon":0},{"id":"2476642194","title":"东曜药业-B上榜10月17日主力资金加仓幅度前10个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2476642194","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476642194?lang=zh_cn&edition=full","pubTime":"2024-10-17 16:16","pubTimestamp":1729152988,"startTime":"0","endTime":"0","summary":"10月17日,东曜药业-B股价收平报1.98元,成交金额801万元,换手率0.52%,振幅5.05%,量比5.49。东曜药业-B今日主力资金净流入792万元,上一交易日主力净流出0万元。该股近5个交易日上涨3.13%,主力资金累计净流入1481万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入2176万元,其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101716170395aeff25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101716170395aeff25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01875","BK1161","BK1574"],"gpt_icon":0},{"id":"2476319157","title":"东曜药业-B(01875)下跌5.05%,报1.88元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2476319157","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476319157?lang=zh_cn&edition=full","pubTime":"2024-10-17 13:00","pubTimestamp":1729141213,"startTime":"0","endTime":"0","summary":"10月17日,东曜药业-B(01875)盘中下跌5.05%,截至13:00,报1.88元/股,成交801.62万元。东曜药业股份有限公司主要业务是提供生物药,特别是抗体偶联药(ADC)的开发生产一站式CDMO解决方案,主力产品已经实现了20,000L的产能。公司拥有一体化的ADC研发平台以及符合GMP规范的大规模生物药商业化生产基地,专门支持多个上市产品的商业化生产,并提供降低转移成本及减少监管风险的一站式解决方案。截至2024年中报,东曜药业-B营业总收入5.21亿元、净利润3155.9万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/17130044096396.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01875","BK1161","BK1574"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.totbiopharm.com.cn","stockEarnings":[{"period":"1week","weight":-0.0643},{"period":"1month","weight":-0.1534},{"period":"3month","weight":-0.2},{"period":"6month","weight":-0.2825},{"period":"1year","weight":-0.2195},{"period":"ytd","weight":-0.1878}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.034},{"period":"3month","weight":0.0464},{"period":"6month","weight":0.0991},{"period":"1year","weight":0.2168},{"period":"ytd","weight":0.1663}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"东曜药业于2019年在香港联交所主板上市,2021年全面转型,致力于成为全球药物开发领域专业CDMO合作伙伴,提供生物药开发到生产一站式解决方案。\n公司拥有从研发、工艺开发、临床试验、注册报批到商业化生产的全流程经验,建立了完整的ADC技术平台,具备核心偶联工艺和放大的技术优势,以及ADC关键质量属性的自主分析能力,保证产品高质量开发。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.091467},{"month":2,"riseRate":0,"avgChangeRate":-0.040488},{"month":3,"riseRate":0.4,"avgChangeRate":-0.046067},{"month":4,"riseRate":1,"avgChangeRate":0.09224},{"month":5,"riseRate":0.6,"avgChangeRate":0.087333},{"month":6,"riseRate":0.6,"avgChangeRate":-0.004749},{"month":7,"riseRate":0.2,"avgChangeRate":-0.031843},{"month":8,"riseRate":0.2,"avgChangeRate":-0.035294},{"month":9,"riseRate":0.6,"avgChangeRate":0.009074},{"month":10,"riseRate":0.4,"avgChangeRate":-0.026839},{"month":11,"riseRate":0,"avgChangeRate":-0.055792},{"month":12,"riseRate":0.666667,"avgChangeRate":-0.035535}],"exchange":"SEHK","name":"东曜药业-B","nameEN":"TOT BIOPHARM-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东曜药业-B(01875)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东曜药业-B(01875)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东曜药业-B,01875,东曜药业-B股票,东曜药业-B股票老虎,东曜药业-B股票老虎国际,东曜药业-B行情,东曜药业-B股票行情,东曜药业-B股价,东曜药业-B股市,东曜药业-B股票价格,东曜药业-B股票交易,东曜药业-B股票购买,东曜药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东曜药业-B(01875)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东曜药业-B(01875)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}